Vials of Johnson & Johnson’s Janssen coronavirus disease (COVID-19) vaccine candidate are seen during the Phase 3 ENSEMBLE trial in an undated photograph.
Johnson & Johnson | via Reuters
A key Food and Drug Administration advisory panel is scheduled to vote Friday on whether to recommend approval of Johnson & Johnson‘s Covid-19 vaccine for emergency use, which would help pave the way to distribute a third preventive treatment in the U.S.
A favorable vote from the Vaccines and Related Biological Products Advisory Committee will likely clear the path for the U.S. agency to approve J&J’s vaccine for emergency use. The committee plays a central role in approving vaccines in the U.S., verifying…